The pharmaceutical industry spends almost twice as much to market the drugs it produces than it does to research and develop them, a recent study found.
US drug companies spent $57.5 billion to promote drugs in 2004, versus $31.5 billion for industrial research and development, Canadian researchers wrote in the January 2 edition of the journal PLoS Medicine, pub
Advertisement
lished by the Public Library of Science (PLoS).
York University researchers Marc-Andre Gagnon and Joel Lexchin analysed data from two market research firms to compile the total amount spent on marketing activities, while the authors cited statistics from the US National Science Foundation for the amount spent on research and development, the journal explained in a statement.
Included in the amount spent on marketing and promotion were free samples, visits from drug representatives, direct-to-consumer advertising, and email and direct mail promotions.
"The authors believe that their figure of $57.5 billion is likely to be an underestimate," the statement said. Their tally does not include ghost-writing of articles in medical journals by drug companies, nor off-label promotion of drugs, the PLoS added. – (HealthDayNews)
Bookmark with:
What are social bookmarks?